Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Sanofi gains FDA clearance for Gaucher disease pill

The approval culminates a winding development journey for Infilbray, and provides Sanofi with a new source of income ahead of Dupixent’s looming patent expiration.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Health & Medicine

More from Thursday 19 November →